Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MSLP > SEC Filings for MSLP > Form 8-K on 26-Mar-2014All Recent SEC Filings

Show all filings for MUSCLEPHARM CORP

Form 8-K for MUSCLEPHARM CORP


26-Mar-2014

Change in Directors or Principal Officers, Other Events, Financial Statements an


ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On March 20, 2014, Sydney Rollock and MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") agreed that Mr. Rollock's title with the Company would be changed from that of Chief Marketing Officer to that of Chief Marketing and Sales Officer. Mr. Rollock will continue to report to the Company's CEO, Brad Pyatt, and his day to day responsibilities will remain the same. The Board of Directors voted to accept this new designation. Mr. Rollock will remain a named executive officer, including for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act").



ITEM 8.01 OTHER EVENTS.

On March 21, 2014, the Company created a Financial Disclosure Committee (the "Committee"), which shall be comprised of certain officers and directors of the Company, as appointed by the Company's Chief Executive Officer for the general purpose of assuring the Company's disclosures to its security holders or the investment community will be accurate and complete and will be made on a timely basis as required by applicable laws and stock exchange requirements. The Committee's charter is attached hereto as Exhibit 99.1.



ITEM 9.01 Financial Statements and Exhibits.

(d) The following are filed as exhibits to this report on Form 8-K.

Exhibit No. Description
99.1 MusclePharm Corporation Financial Disclosure Committee Charter

  Add MSLP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MSLP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.